Global Oral Contrast Agent Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Oral Contrast Agent Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Product
- 1.4.2 Barium-based Contrast Media
- 1.4.3 Iodinated Contrast Media
- 1.4.4 Gadolinium-based Contrast Media
- 1.4.5 Microbubble Contrast Media
- 1.5 Market by End User
- 1.5.1 Global Oral Contrast Agent Market Size Growth Rate by End User
- 1.5.2 Cardiovascular Disorders
- 1.5.3 Cancer
- 1.5.4 Gastrointestinal Disorders
- 1.5.5 Musculoskeletal Disorders
- 1.5.6 Neurological Disorders
- 1.5.7 Nephrological Disorders
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oral Contrast Agent Market Size
- 2.1.1 Global Oral Contrast Agent Revenue 2014-2025
- 2.1.2 Global Oral Contrast Agent Sales 2014-2025
- 2.2 Oral Contrast Agent Growth Rate by Regions
- 2.2.1 Global Oral Contrast Agent Sales by Regions
- 2.2.2 Global Oral Contrast Agent Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oral Contrast Agent Sales by Manufacturers
- 3.1.1 Oral Contrast Agent Sales by Manufacturers
- 3.1.2 Oral Contrast Agent Sales Market Share by Manufacturers
- 3.1.3 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI)
- 3.2 Oral Contrast Agent Revenue by Manufacturers
- 3.2.1 Oral Contrast Agent Revenue by Manufacturers (2014-2019)
- 3.2.2 Oral Contrast Agent Revenue Share by Manufacturers (2014-2019)
- 3.3 Oral Contrast Agent Price by Manufacturers
- 3.4 Oral Contrast Agent Manufacturing Base Distribution, Product Types
- 3.4.1 Oral Contrast Agent Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oral Contrast Agent Product Type
- 3.4.3 Date of International Manufacturers Enter into Oral Contrast Agent Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Oral Contrast Agent Sales by Product
- 4.2 Global Oral Contrast Agent Revenue by Product
- 4.3 Oral Contrast Agent Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Oral Contrast Agent Breakdown Data by End User
6 North America
- 6.1 North America Oral Contrast Agent by Countries
- 6.1.1 North America Oral Contrast Agent Sales by Countries
- 6.1.2 North America Oral Contrast Agent Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oral Contrast Agent by Product
- 6.3 North America Oral Contrast Agent by End User
7 Europe
- 7.1 Europe Oral Contrast Agent by Countries
- 7.1.1 Europe Oral Contrast Agent Sales by Countries
- 7.1.2 Europe Oral Contrast Agent Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oral Contrast Agent by Product
- 7.3 Europe Oral Contrast Agent by End User
8 Asia Pacific
- 8.1 Asia Pacific Oral Contrast Agent by Countries
- 8.1.1 Asia Pacific Oral Contrast Agent Sales by Countries
- 8.1.2 Asia Pacific Oral Contrast Agent Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Oral Contrast Agent by Product
- 8.3 Asia Pacific Oral Contrast Agent by End User
9 Central & South America
- 9.1 Central & South America Oral Contrast Agent by Countries
- 9.1.1 Central & South America Oral Contrast Agent Sales by Countries
- 9.1.2 Central & South America Oral Contrast Agent Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Oral Contrast Agent by Product
- 9.3 Central & South America Oral Contrast Agent by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Oral Contrast Agent by Countries
- 10.1.1 Middle East and Africa Oral Contrast Agent Sales by Countries
- 10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oral Contrast Agent by Product
- 10.3 Middle East and Africa Oral Contrast Agent by End User
11 Company Profiles
- 11.1 GE Healthcare (US)
- 11.1.1 GE Healthcare (US) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered
- 11.1.5 GE Healthcare (US) Recent Development
- 11.2 Bracco Imaging (Italy)
- 11.2.1 Bracco Imaging (Italy) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products Offered
- 11.2.5 Bracco Imaging (Italy) Recent Development
- 11.3 Bayer HealthCare (Germany)
- 11.3.1 Bayer HealthCare (Germany) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products Offered
- 11.3.5 Bayer HealthCare (Germany) Recent Development
- 11.4 Guerbet (France)
- 11.4.1 Guerbet (France) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Guerbet (France) Oral Contrast Agent Products Offered
- 11.4.5 Guerbet (France) Recent Development
- 11.5 Lantheus (US)
- 11.5.1 Lantheus (US) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Lantheus (US) Oral Contrast Agent Products Offered
- 11.5.5 Lantheus (US) Recent Development
- 11.6 Daiichi Sankyo (Japan)
- 11.6.1 Daiichi Sankyo (Japan) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products Offered
- 11.6.5 Daiichi Sankyo (Japan) Recent Development
- 11.7 Unijules Life Sciences (India)
- 11.7.1 Unijules Life Sciences (India) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products Offered
- 11.7.5 Unijules Life Sciences (India) Recent Development
- 11.8 J.B. Chemicals and Pharmaceuticals (India)
- 11.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products Offered
- 11.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Development
- 11.9 Spago Nanomedicine (Sweden)
- 11.9.1 Spago Nanomedicine (Sweden) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products Offered
- 11.9.5 Spago Nanomedicine (Sweden) Recent Development
- 11.10 Taejoon Pharm (South Korea)
- 11.10.1 Taejoon Pharm (South Korea) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products Offered
- 11.10.5 Taejoon Pharm (South Korea) Recent Development
- 11.11 Jodas (India)
- 11.12 Magnus Health (India)
12 Future Forecast
- 12.1 Oral Contrast Agent Market Forecast by Regions
- 12.1.1 Global Oral Contrast Agent Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oral Contrast Agent Revenue Forecast by Regions 2019-2025
- 12.2 Oral Contrast Agent Market Forecast by Product
- 12.2.1 Global Oral Contrast Agent Sales Forecast by Product 2019-2025
- 12.2.2 Global Oral Contrast Agent Revenue Forecast by Product 2019-2025
- 12.3 Oral Contrast Agent Market Forecast by End User
- 12.4 North America Oral Contrast Agent Forecast
- 12.5 Europe Oral Contrast Agent Forecast
- 12.6 Asia Pacific Oral Contrast Agent Forecast
- 12.7 Central & South America Oral Contrast Agent Forecast
- 12.8 Middle East and Africa Oral Contrast Agent Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oral Contrast Agent Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Oral Contrast Agent market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Contrast Agent market based on company, product type, end user and key regions.
This report studies the global market size of Oral Contrast Agent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Contrast Agent in these regions.
This research report categorizes the global Oral Contrast Agent market by top players/brands, region, type and end user. This report also studies the global Oral Contrast Agent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Market size by Product
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Market size by End User
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oral Contrast Agent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral Contrast Agent market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Contrast Agent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral Contrast Agent submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oral Contrast Agent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Contrast Agent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.